Moore Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,501
| Closed | -$676K | – | 811 |
|
|
2022
Q1 | $676K | Buy |
+19,501
| New | +$676K | 0.02% | 428 |
|
|
2021
Q1 | – | Sell |
-86,915
| Closed | -$3.76M | – | 829 |
|
|
2020
Q4 | $3.76M | Sell |
86,915
-24,830
| -22% | -$1.08M | 0.04% | 275 |
|
|
2020
Q3 | $6.16M | Buy |
+111,745
| New | +$6.16M | 0.12% | 146 |
|
|
2017
Q1 | – | Sell |
-75,000
| Closed | -$1.08M | – | 227 |
|
|
2016
Q4 | $1.08M | Buy |
+75,000
| New | +$1.08M | 0.04% | 124 |
|
|
2016
Q1 | – | Sell |
-40,000
| Closed | -$1.29M | – | 334 |
|
|
2015
Q4 | $1.29M | Buy |
+40,000
| New | +$1.29M | 0.04% | 213 |
|